Showing results (61-70 of 324) with videos related to
Sort By:
Pageof 33
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 8, 2016
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with OsimertinibChao-Chi Ho, Wei-Yu Liao, Chih-An Lin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2020
Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 CasesJames Chih-Hsin Yang, Martin Schuler, Sanjay Popat, et al.Case Reports in Oncology|October 11, 2016
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung CancerShao-Lun Lu, Feng-Ming Hsu, Kuan-Yu Chen, et al.International Journal of Molecular Sciences|December 6, 2016
Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80Kuan-Hung Lin, Shu-Ting Hong, Hsiang-Tsui Wang, et al.Clinical Lung Cancer|July 16, 2010
Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancerJenn-Yu Wu, Chih-Hsin Yang, Ya-Chieh Hsu, et al.BMC Cancer|June 15, 2012
Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factorsChia-Lin Hsu, Kuan-Yu Chen, Jin-Yuan Shih, et al.International Journal of Cancer|June 19, 2009
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancerJenn-Yu Wu, Jin-Yuan Shih, Chih-Hsin Yang, et al.European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancerYu-Yun Shao, Wen-Yi Shau, Zhong-Zhe Lin, et al.Cancer Research|August 3, 2005
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family proteinChih-Hsin Yang, Ching-Ju Huang, Chao-Shun Yang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2012
Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinumWei-Yu Liao, Jin-Yuan Shih, Gee-Chen Chang, et al.Pageof 33